Investor
Info
-Annual Report
-Annual Report
DNA Sequencing
-DNA Sequencing
-Genome Sequencing
-Computer-based
Homology Searches
Nucleic Acid Synthesis
-DNA/RNA/PNA Synthesis
-Gene Synthesis
Peptide Technologies
-Peptide Synthesis
-Amino Acid Synthesis
-Peptide Sequencing
Protein Technologies
-Protein (N- and C- Terminal) Sequencing
-Monoclonal & Polyclonal Antibodies
-Purification
-Overexpression Projects
-Peptide Mapping
-Computer-based homology searches
Molecular Biology
-Plasmid
Preparation
-Cloning & Overexpression Projects
-Site-directed Mutagenesis
-Genomic or cDNA Libraries
-Library Screening
-Northern or Southern Blot Analysis
-Computer Based Homology Searches
Genetic Testing Services
-Human
Genetic Analysis
-Veterinary Genetic Analysis
-DNA Identity testing (CODIS Databasing)
-DNA Fingerprinting
Biophysical Analysis
-Mass
Spectrometry
-Calorimetry
Text Home Page
Graphics
Version
| Commonwealth Biotechnologies, Inc. (CBI) is the most comprehensive Contract Research Organization in the market today, offering cutting-edge expertise and a complete array of the most current analytical and synthetic chemistries and biophysical technologies, many of which are not available from any other source. Our broad technology base coupled with the assignment of an experienced senior scientist to oversee every project allows CBI to offer true customized project design and management to support your specific needs. CBI's fully automated instrumentation offers rapid turnaround time and accurate results. You have complete access to an experienced staff of highly skilled molecular biologists, geneticists, biochemists, and chemists to respond to your questions about protocols, results, or pricing. CBI is prepared to take your project from start to finish by offering technical expertise and a complete array of analytical and synthetic chemistries to support your research efforts. We invite you to take a moment to look over the descriptions of CBI's comprehensive services. CBI can offer a discount on selected technologies for investigators at not-for-profit institutions. |
| ACCUTRAC New loading buffer provides a marking tool for sample tracking of automated DNA sequencers |
HEPARREST Recently patented lead pharmaceutical candidate for the reversal of heparin-enduced anticoagulation |
Commonwealth
Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 / FAX: 804-648-2641
Toll-Free FAX on Demand: (877) FAX-4-CBI
email: [email protected]
601 Biotech Drive, Richmond, VA 23235
800-735-9224 / FAX: 804-648-2641
Toll-Free FAX on Demand: (877) FAX-4-CBI
email: [email protected]